Candida albicans is a major fungal pathogen that causes serious systemic and mucosal infections in immunocompromised individuals. In yeast, histone H3 Lys56 acetylation (H3K56ac) is an abundant modification regulated by enzymes that have fungal-specific properties, making them appealing targets for antifungal therapy. Here we demonstrate that H3K56ac in C. albicans is regulated by the RTT109 and HST3 genes, which respectively encode the H3K56 acetyltransferase (Rtt109p) and deacetylase (Hst3p). We show that reduced levels of H3K56ac sensitize C. albicans to genotoxic and antifungal agents. Inhibition of Hst3p activity by conditional gene repression or nicotinamide treatment results in a loss of cell viability associated with abnormal filamentous growth, histone degradation and gross aberrations in DNA staining. We show that genetic or pharmacological alterations in H3K56ac levels reduce virulence in a mouse model of C. albicans infection. Our results demonstrate that modulation of H3K56ac is a unique strategy for treatment of C. albicans and, possibly, other fungal infections.
H3K56ac is an abundant post-translational modification found in newly synthesized H3 molecules deposited throughout the genome during DNA replication 1, 2 . Originally discovered in yeast [2] [3] [4] [5] [6] , H3K56ac also occurs in human cells [7] [8] [9] [10] . In Saccharomyces cerevisiae, H3K56ac peaks when new histones are synthesized during S phase 2 and is mediated by the histone acetyltransferase Rtt109p [11] [12] [13] . H3K56ac is removed genome-wide by the histone deacetylases Hst3p and Hst4p during the G2 and M phases 1, 14 . Tightly regulated H3K56ac plays a key part in the DNA damage response, as mutants that cannot acetylate or deacetylate Lys56 are extremely sensitive to genotoxic agents 1, 2, 12, 14, 15 .
C. albicans is a major human fungal pathogen in terms of both its clinical importance and its use as an experimental model for fungal pathogenesis 16, 17 . It is one of the leading causes of infections affecting immunodeficient individuals, including HIV-infected individuals and patients undergoing cancer therapy. C. albicans is the fourth most common cause of nosocomial bloodstream infections in the US and is associated with high mortality rates [18] [19] [20] . Treatment of candidiasis involves the use of azole or echinocandin drugs that target ergosterol and cell wall biosynthesis, respectively, but their efficacy can be compromised by the emergence of drug-resistant strains 21, 22 . As the fungal enzymes that regulate H3K56ac have diverged considerably from their human counterparts 23, 24 , we sought to determine whether these enzymes could be potential targets for treatment of C. albicans infections.
RESULTS

H3K56ac modulates fungicidal agent sensitivity in C. albicans
We first verified the presence of H3K56ac in C. albicans. Immunoblots of total lysates from SC5314 and SN152 strains probed with an antibody against H3K56ac 1,2 revealed a band of the expected molecular weight (~15 kDa) (Fig. 1a) . We also isolated histones from C. albicans cells and analyzed them by mass spectrometry. The product ion spectrum of a doubly protonated precursor peptide (m/z 638.9 2+ ) shows a y-type fragment ion series that confirms acetylation of Lys56 on the basis of the the 42-Da mass shift between the y7 and y8 fragment ions (Fig. 1b) . We also estimated the stoichiometry of H3K56ac by derivatization of nonmodified lysine ε-amino groups with deuterated acetic anhydride before trypsin digestion 1, 2 . In asynchronously growing cultures, the Lys56-acetylated peptide was present in 20% to 27% of H3 molecules (Fig. 1c,d ). Thus, H3K56ac is an abundant modification in C. albicans. This is in stark contrast to the low stoichiometry of H3K56ac (1%) in human cells 7, 9 .
The RTT109 gene encodes an acetyltransferase responsible for H3K56ac [11] [12] [13] ; its ortholog in C. albicans is orf19.7491 (RTT109). Deletion of both alleles of RTT109 in strain SN152 ( Supplementary  Fig. 1 ) led to nearly complete disappearance of H3K56ac on the basis of immunoblots and mass spectrometry (Fig. 1a,d and Supplementary Table 1) . Deacetylation of H3K56 requires the sirtuins Hst3p and Hst4p in S. cerevisiae. Deletion of both genes results in DNA damage sensitivity and thermosensitivity, but the double mutant remains viable 1, 14, 15 . We only found one gene in C. albicans (orf19.1934; HST3) encoding a potential ortholog of S. cerevisiae HST3 and HST4. We generated a heterozygous deletion mutant for HST3 in SN152, but were unable to obtain an hst3Δ/hst3Δ (hst3Δ/Δ hereafter) homozygous mutant, suggesting that the C. albicans HST3 gene is essential. Although immunoblots of whole-cell extracts from hst3Δ/HST3 (HST3+/Δ hereafter) cells failed to detect an increase in H3K56ac (Fig. 1a) , the stoichiometry of H3K56ac monitored by quantitative mass spectrometry was twofold higher than in wild-type cells ( Fig. 1d and Supplementary Table 1) .
We studied the survival of C. albicans rtt109 and hst3 mutants treated with genotoxic and antifungal agents. Deletion of both alleles of RTT109 conferred sensitivity to hydroxyurea and methyl methane sulfonate (Fig. 1e) . HST3+/Δ heterozygous mutants were also sensitive to these agents (Fig. 1e) . We also tested the susceptibility of these mutants to two families of antifungal agents: azoles (fluconazole) and echinocandins (caspofungin, micafungin). We found that rtt109Δ/ rtt109Δ (rtt109Δ/Δ hereafter) and HST3+/Δ cells were no more susceptible to fluconazole than wild-type cells, but the rtt109Δ/Δ strain was very sensitive to both echinocandins (Fig. 1e) . Because echinocandins induce oxidative stress 25 , we tested whether the echinocandin sensitivity of rtt109Δ/Δ mutants could be suppressed by antioxidants. The antioxidants N-acetyl-l-cysteine and vitamin C restored viability of rtt109Δ/Δ mutant cells exposed to micafungin (Fig. 1e) . These results show that genetic perturbation of H3K56ac sensitizes C. albicans to genotoxic and antifungal drugs.
H3K56 deacetylation by Hst3p is essential in C. albicans Because we were unable to obtain a homozygous hst3Δ/Δ mutant, we generated strains in the CaSS1 background 26 , in which we deleted one copy of the HST3 gene and placed the other copy under the control of a promoter that can be repressed with doxycycline (hst3Δ/pTET-HST3, Supplementary Methods and Supplementary Fig. 2c−e) . Addition of doxycycline to hst3Δ/pTET-HST3 cells resulted in a strong decrease in HST3 mRNA levels and a concomitant increase in H3K56ac (Fig. 2a,b) . To confirm this result, we isolated histones either before or after doxycycline addition and determined the stoichiometry of modification by mass spectrometry. We found that the fraction of H3 molecules that were Lys56-acetylated increased from 48% to 87% when we treated the hst3Δ/pTET-HST3 strain with doxycycline for 7.5 h (Fig. 2c and Supplementary Table 1) . The degree of acetylation of other lysine residues in the N-terminal tail of H3 did not increase upon HST3 repression with doxycycline (Supplementary Table 1) . To obtain equal amounts of histone H3 for immunoblotting, we needed to load increasing amounts of total protein as a function of time after doxycycline addition (Fig. 2b) . Immunoblots of wholecell lysates from equal numbers of cells confirmed that the amounts of both H3 and H4 declined over time after doxycycline addition to hst3Δ/pTET-HST3 cells (Fig. 2b) . This time-dependent loss of H3 and H4 suggests that HST3 repression leads to pronounced changes in chromatin structure.
Repression of HST3 expression with doxycycline severely impaired the growth of hst3Δ/pTET-HST3 cells (Fig. 2d) . To determine whether repression of HST3 was fungistatic or fungicidal, we performed colony formation assays after transient doxycycline exposure. We grew tenfold serial dilutions of hst3Δ/pTET-HST3 and control cells in liquid cultures in the presence or absence of doxycycline for 24 h and then transferred the cells to solid medium lacking doxycycline. We found that the number of colony-forming units in hst3Δ/pTET-HST3 cultures was much lower after a 24 h exposure to doxycycline (Fig. 2e) compared to control cells, suggesting that transient HST3 repression led to cell death. To confirm this, we used propidium iodide staining of nucleic acids as a measure of cell death; live cells are not permeable to propidium ions 27 . Almost all hst3Δ/pTET-HST3 cells killed with heat (65 °C for 30 min) or treated for 24 h with doxycycline stained with propidium iodide (Fig. 2f) . We also observed that HST3 repression with doxycycline triggered anomalous filamentous growth (Fig. 2f) . It was possible that filamentous growth in itself could increase propidium iodide staining, irrespective of cell viability. To rule out this possibility, we grew hst3Δ/pTET-HST3 cells in the absence of doxycycline but under conditions that induce a switch to filamentous growth. We found that the resulting filaments were negative for propidium iodide staining (Fig. 2f ). These results demonstrate that, unlike in S. cerevisiae and Schizosaccharomyces pombe, repression of HST3 in C. albicans leads to a loss of cell viability. We hypothesized that the high levels of H3K56ac induced by repression of HST3 were causing cell death. This model predicts that deletion of the RTT109 acetyltransferase gene should rescue the lethality of the hst3Δ/Δ mutant. Consistent with this, we were able to delete both alleles of the HST3 gene in the rtt109Δ/Δ genetic background ( Fig. 2g and Supplementary Fig. 2f-h ). The rtt109Δ/Δ hst3+/Δ and rtt109Δ/Δ hst3Δ/Δ mutants were not more susceptible to genotoxic agents than the rtt109Δ/Δ strain, although they grew more slowly than either rtt109Δ/Δ or hst3+/Δ mutants ( Fig. 2g and Supplementary  Fig. 2h ). These results demonstrate that the lethality of hst3Δ/Δ mutants depends upon the RTT109 gene. Therefore, we conclude that H3 Lys56 hyperacetylation is toxic to C. albicans cells and that H3K56ac is a major physiological substrate of C. albicans Hst3p.
Under conditions that normally maintain the yeast form of C. albicans, HST3 repression with doxycyline triggered a transition to filamentous growth (Fig. 3a) . True hyphae typically lack constrictions at sites of septation and have narrow (~2-μm) parallel cell walls along their entire length 28 . In contrast, pseudohyphae have visible constrictions at sites of septation 28 . To determine whether HST3 repression produced true hyphae, we stained hst3Δ/pTET-HST3 cells grown in doxycycline-containing medium with DAPI and calcofluor white to visualize DNA, cell walls and septa. Cells initially appeared to divide normally, as we observed many budded cells after 3 h of doxycycline treatment (Fig. 3b) . After 6 h, we observed pseudohyphae-like cells with septal junctions (Fig. 3b) . Notably, at later time points (9 and 24 h), most cells appeared as abnormal 'V-shaped' filaments (Fig. 3b) . In contrast to HST3 repression, hst3Δ/pTET-HST3 cells in spider medium lacking doxycycline (conditions that preserve HST3 expression) produced hyphae with parallel-sided, narrow germ tubes and no clear septal junctions (Fig. 3a) . These features are clearly different from the morphological changes observed after repression of HST3 (Fig. 3b) . After 9 h and 24 h of doxycycline treatment, hst3Δ/pTET-HST3 cells showed diffuse or absent DAPI staining (Fig. 3b) HST3 repression resulted in DNA fragmentation and degradation. This is consistent with the presence of high levels of spontaneous DNA damage previously reported in S. cerevisiae hst3Δ hst4Δ mutants 1 . These results indicate that inappropriately high levels of H3K56ac lead to DNA fragmentation, histone H3 and H4 degradation and an anomalous morphological transition that culminate in cell death. Remarkably, all of these events occurred when the stoichiometry of H3K56ac increased from about 48% to 87% after HST3 gene repression (Fig. 2c and Supplementary Table 1) . Some of these pronounced phenotypes were not reported in S. cerevisiae and S. pombe cells that lack H3K56 deacetylases 1, 14, 15, 29, 30 . In addition, we observed that a fraction of rtt109Δ/Δ cells (about 10%) spontaneously formed pseudohyphae with abnormal nuclear DNA staining (Supplementary Fig. 1g ), indicating that tightly regulated levels of H3K56ac are crucial for proper chromatin structure and morphogenesis in C. albicans.
Hst3p inhibition with nicotinamide is cytotoxic to C. albicans
Hst3p is a member of a family of NAD + -dependent histone deacetylases known as sirtuins (Supplementary Fig. 3 ). These enzymes are inhibited by nicotinamide, a product of the NAD + -dependent deacetylation reaction. We reasoned that nicotinamide treatment of C. albicans cells should phenocopy HST3 repression. Addition of nicotinamide to wild-type cells caused an increase in H3K56ac (Fig. 4a) and led to robust growth inhibition (Fig. 4b,c) . Furthermore, growth inhibition was not observed with nicotinic acid, which does not inhibit Hst3p 1 , and was RTT109 dependent (Fig. 4b,c) . This suggests that nicotinamide exerts its effect through inhibition of H3K56 deacetylation. Finally, incubation of wild-type cells for 24 h with nicotinamide triggered the formation of V-shaped filaments with abnormal DNA staining (Fig. 4d) , similar to those observed in doxycycline-treated hst3Δ/pTET-HST3 cells (Fig. 3b) .
These results prompted us to determine whether other clinically relevant isolates of C. albicans and fungal species are susceptible to growth inhibition by nicotinamide. Several azole-and echinocandinresistant clinical isolates of C. albicans were as sensitive to nicotinamide as a wild-type strain (Figs. 4c and 5a and Supplementary  Fig. 4) . We also found that other pathogenic Candida species were susceptible to nicotinamide. We observed robust growth inhibition of C. krusei at 25 mM nicotinamide, whereas growth of C. tropicalis, C. glabrata and C. parapsilosis was inhibited at higher nicotinamide concentrations (Fig. 5b) . Nicotinamide also strongly inhibited the growth of Aspergillus fumigatus and Aspergillus nidulans, which are pathogenic to humans and plants, respectively (Fig. 5c ). These results demonstrate that nicotinamide has broad antifungal properties.
Modulation of H3K56ac reduces C. albicans virulence in mice
We investigated the effect of H3K56ac modulation on C. albicans virulence in A/J mice, which are very sensitive to C. albicans infection 31, 32 . This phenotype results, at least in part, from a deficiency in the C5 component of the complement system 33 . A/J mice accumulate high fungal loads within 24 h, providing a convenient model to rapidly and accurately measure fungal proliferation in vivo 32 . We first investigated the effect of HST3 repression on C. albicans virulence. A/J mice were injected with wild-type (SC5314 or KTY3) or hst3Δ/pTET-HST3 cells, and tetracycline was included in the drinking water of the mice to repress HST3. The kidney fungal loads of mice injected with hst3Δ/pTET-HST3 cells were markedly lower than those of mice injected with wild-type strains (Fig. 6a) . In addition, clinical symptoms typical of a C. albicans infection were not visible in mice injected with hst3Δ/pTET-HST3 cells (data not shown). We next determined whether nicotinamide treatment would mimic the effect of HST3 repression in vivo. We gave mice nicotinamide 30 min before and 8 h after infection with C. albicans. Nicotinamide greatly lowered kidney fungal loads and clearly alleviated clinical signs of disease progression in mice injected with wild-type cells (Fig. 6b) . In contrast, nicotinamide failed to protect mice injected with rtt109Δ/Δ cells, both in terms of fungal load and in terms of symptoms of candidiasis (Fig. 6b) . As expected, introduction of a wild-type RTT109 gene into rtt109Δ/Δ cells reestablished sensitivity to nicotinamide (Fig. 6b) . Nicotinamide has been reported to have complex immunomodulatory effects in mammals 34 . However, under our experimental conditions, nicotinamide had no obvious side effects, as judged by the absence of various inflammation markers (Supplementary Table 4) and by careful monitoring of the mice. Furthermore, the fact that the antifungal effect of nicotinamide requires RTT109-dependent H3K56ac firmly establishes that nicotinamide exerts its therapeutic effect through inhibition of Hst3p-mediated H3K56 deacetylation, rather than by enhancing the host immune response. These results indicate that genetic or pharmacological inhibition of Hst3p leads to a loss of virulence in mice. We also investigated the effect of the RTT109 deletion on virulence. We injected A/J mice intravenously with wild-type, rtt109Δ/Δ or rtt109Δ/Δ+RTT109 revertant cells. At the time of killing (24 h after infection), only mice injected with wild-type and revertant cells showed clinical manifestations of advanced candidiasis (data not shown). This prompted us to investigate the effect of RTT109 deletion on other parameters of C. albicans virulence. A/J mice suffer from cardiac dysfunction and accumulate high fungal loads in kidneys and the heart 32 . We found reduced fungal loads in the heart and kidneys of mice infected with rtt109Δ/Δ as compared with wildtype or revertant cells (Fig. 6c) . We also observed that, compared with wild-type and revertant strains, the rtt109Δ/Δ mutant elicited a weaker inflammatory response in A/J mice, as evidenced by significantly lower amounts of interleukin-6, a key proinflammatory cytokine, and keratinocyte-derived chemokine, which is crucial for granulocyte recruitment (Fig. 6d) . These results show that loss of Rtt109p reduces the virulence of C. albicans in A/J mice.
DISCUSSION
Two major classes of chemicals are commonly used to treat candidiasis: azoles and echinocandins. However, the emergence of strains that are resistant to these agents requires the development of new approaches to clinical intervention. In this report, we have identified two enzymes as attractive new therapeutic targets to treat C. albicans infections and possibly those caused by other pathogenic fungi. These enzymes, Rtt109p and Hst3/Hst4p, respectively acetylate and deacetylate histone H3K56 in C. albicans, S. cerevisiae and S. pombe 1, [11] [12] [13] [14] [15] 29, 30 , and potential orthologs exist in several other pathogenic fungi. In C. albicans, disruption of the RTT109 gene conferred acute sensitivity to two distinct echinocandin family members, and this sensitivity was suppressed by antioxidants. Given that RTT109 mutations render C. albicans and other yeasts sensitive to genotoxic agents that impede DNA replication [11] [12] [13] 29, 30 , it seems likely that the marked echinocandin sensitivity of rtt109 mutants arises from oxidative damage to DNA 35 . Deletion of RTT109 also leads to pseudohyphae formation and reduces the growth rate of C. albicans in rich medium. Concordant with this, we found that rtt109Δ/Δ mutants are less virulent than wild-type C. albicans cells in the A/J mouse model. Given these results, Rtt109p inhibitors would be expected to enhance the cytotoxicity of echinocandins and reduce the virulence of C. albicans. CREB-binding protein (CBP) and p300 acetylate H3K56 and other substrates in human cells 7, 23 . Despite similarities in their polypeptide backbones suggesting an ancestral relationship, the catalytic cores, catalytic mechanisms and substrate specificity of yeast Rtt109p and human p300/CBP are vastly different 23 . Therefore, it is likely that chemical library screens could identify specific inhibitors of Rtt109p that do not affect human p300/CBP. We found that repression of the C. albicans HST3 gene is lethal even in the absence of antifungal agent. In A/J mice, Hst3p inhibition by gene repression or nicotinamide treatment considerably reduced C. albicans proliferation and clinical manifestations of candidiasis. Nicotinamide is a vitamin that serves as a precursor of NAD + . It is well tolerated and used systemically to treat pellagra and skin lesions 36, 37 . Despite its beneficial effects, complex immunomodulatory effects of nicotinamide have been reported in mammalian cells 34 . This suggests that the ability of nicotinamide to curtail C. albicans infection might be due to an enhanced immune response of the host. However, three lines of evidence firmly establish that the main therapeutic effect of nicotinamide is exerted through inhibition of Hst3p, thus blocking H3K56 deacetylation. First, nicotinamide is not cytotoxic to C. albicans cells lacking Rtt109p and H3K56ac. Second, the antifungal property of nicotinamide in A/J mice depends on the presence of the RTT109 gene. Third, as judged by the absence of various inflammation markers, short-term nicotinamide treatment has no obvious immunomodulatory effects under our experimental conditions.
There are sound biochemical arguments to indicate that selective inhibitors of Hst3p may not have major side effects in humans. Despite the fact that sirtuin-1 (SIRT1) and SIRT2 have been implicated in H3K56 deacetylation in human cells 7, 10 , there are sequence motifs conserved among fungal Hst3p family members that are absent from human sirtuins 24 . For instance, differences occur in the peptide binding channel of sirtuins 38 . Unlike human SIRT1 and SIRT2 (refs. 39-41), Hst3p seems to be highly substrate specific. In S. cerevisiae 1 or C. albicans (Supplementary Table 1) , acetylation of several sites in the N-terminal tails of H3 or H4 does not increase in the absence of Hst3 or Hst4p. Hence, it is conceivable that small molecules that specifically block the deacetylase activity of fungal Hst3p orthologs, without affecting human sirtuins, might be identified. Indeed, small molecules that inhibit even closely related sirtuins with high selectivity have been identified by screening chemical libraries 42 .
We determined the sensitivity to nicotinamide of a broad spectrum of fungal species. All of the C. albicans clinical isolates tested, including azole-and echinocandin-resistant strains, were very sensitive to nicotinamide. This is clinically important because, among the numerous species that cause candidiasis, C. albicans is responsible for the majority of cases 43 and frequently develops resistance to azoles and echinocandins 21, 22 . The non-albicans Candida strains that we tested showed various degrees of sensitivity. The strong sensitivity of C. krusei to nicotinamide is of particular interest, because C. krusei is intrinsically resistant to many antifungal drugs 44 . We also found that two different Aspergillus species, A. fumigatus and A. nidulans, were very sensitive to nicotinamide. This is noteworthy because A. fumigatus causes the second most common invasive mycoses in humans, after candidiasis 45 . Our data thus support the notion that nicotinamide or future fungal-specific sirtuin inhibitors may prove useful to treat various fungal infections and provide a solid physiological and molecular basis for the development of new antifungal agents that inhibit the enzymes that regulate H3K56ac. Although further in vivo studies will be necessary to assess the true therapeutic potential of nicotinamide and related chemicals, our results constitute a proof of principle that this strategy represents a useful therapeutic avenue.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemedicine/.
Note: Supplementary information is available on the Nature Medicine website.
